Search research articles
Contact Us
Filters
Showing results (11-20 of 88) with videos related to
Page
of 9
Sort By:
Expert Opinion on Pharmacotherapy
|
July 17, 2008
Major bleeding: management and risk reduction in acute coronary syndromes
Matthew A Cavender, Sunil V Rao, E Magnus Ohman
Clinical Diabetes : a Publication of the American Diabetes Association
|
November 16, 2022
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases
Pamela R Kushner, Matthew A Cavender, Christian W Mende
Circulation. Cardiovascular Interventions
|
July 17, 2020
Novel Oral Anticoagulants Following Percutaneous Coronary Intervention
Bryan Q Abadie, Christopher P Cannon, Matthew A Cavender
Postgraduate Medicine
|
September 11, 2023
Cardiorenal care coordination: holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease
Eden Miller, Dominic Raj, Matthew A Cavender, et al.
Cardiorenal Medicine
|
June 16, 2024
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Tarlan Namvar, Matthew A Cavender, Eden Miller, et al.
European Heart Journal. Case Reports
|
January 9, 2020
Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report
Jonathan D Cicci, Sarah M Jagielski, Megan M Clarke, et al.
The Journal of Invasive Cardiology
|
September 28, 2023
Sex differences in device-measured physical activity after transcatheter aortic valve replacement
Anthony J Mazzella, Anil K Gehi, Ryan Searcy, et al.
Circulation
|
August 30, 2017
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Michael A Nauck, Juris J Meier, Matthew A Cavender, et al.
The Lancet. Diabetes & Endocrinology
|
March 21, 2015
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
Jacob A Udell, Matthew A Cavender, Deepak L Bhatt, et al.
The American Journal of Cardiology
|
August 8, 2009
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)
Matthew A Cavender, Sarah Milford-Beland, Matthew T Roe, et al.
Page
of 9
Search research articles
Search
Showing results (11-20 of 88) with videos related to
Sort By:
Page
of 9
Expert Opinion on Pharmacotherapy
|
July 17, 2008
Major bleeding: management and risk reduction in acute coronary syndromes
Matthew A Cavender, Sunil V Rao, E Magnus Ohman
Clinical Diabetes : a Publication of the American Diabetes Association
|
November 16, 2022
Role of Primary Care Clinicians in the Management of Patients With Type 2 Diabetes and Cardiorenal Diseases
Pamela R Kushner, Matthew A Cavender, Christian W Mende
Circulation. Cardiovascular Interventions
|
July 17, 2020
Novel Oral Anticoagulants Following Percutaneous Coronary Intervention
Bryan Q Abadie, Christopher P Cannon, Matthew A Cavender
Postgraduate Medicine
|
September 11, 2023
Cardiorenal care coordination: holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease
Eden Miller, Dominic Raj, Matthew A Cavender, et al.
Cardiorenal Medicine
|
June 16, 2024
Perspectives in Managing Kidney Disease and Atherosclerotic Cardiovascular Disease
Tarlan Namvar, Matthew A Cavender, Eden Miller, et al.
European Heart Journal. Case Reports
|
January 9, 2020
Loperamide overdose causing torsades de pointes and requiring Impella temporary mechanical support: a case report
Jonathan D Cicci, Sarah M Jagielski, Megan M Clarke, et al.
The Journal of Invasive Cardiology
|
September 28, 2023
Sex differences in device-measured physical activity after transcatheter aortic valve replacement
Anthony J Mazzella, Anil K Gehi, Ryan Searcy, et al.
Circulation
|
August 30, 2017
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors
Michael A Nauck, Juris J Meier, Matthew A Cavender, et al.
The Lancet. Diabetes & Endocrinology
|
March 21, 2015
Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials
Jacob A Udell, Matthew A Cavender, Deepak L Bhatt, et al.
The American Journal of Cardiology
|
August 8, 2009
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)
Matthew A Cavender, Sarah Milford-Beland, Matthew T Roe, et al.
Page
of 9